Mbole E. is currently serving as the Biomarker Operations Lead at BioNTech SE, a position held since 2024, where expertise in biomarker operational activities for oncology trials is provided. Prior to this role, Mbole E. managed the Biosample Operations team at Nurix Therapeutics from 2021 to 2024, focusing on aligning Translational Medicine goals with efficient processes. Experience also includes management of biosample operations at HOOKIPA Pharma Inc. (2020-2021), and significant roles at Regeneron (2015-2020) as a Senior Precision Medicine Associate, Roche (2011-2015) as a Biosample Operations Manager, and Hackensack University Medical Center (2009-2011) as an Oncology Research Coordinator. Educational credentials include an MS in Healthcare Systems Management and an MS in Pharmaceutical Systems Management from the New Jersey Institute of Technology, along with a Mini-MBA™ in BioPharma Innovation from Rutgers Business School.
This person is not in any teams
This person is not in any offices